NCT03229876 2023-07-24Safety and Efficacy Evaluation of CD19-UCARTBioray LaboratoriesPhase NA Suspended20 enrolled
NCT00077493 2007-12-28BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's LymphomaMedImmune LLCPhase 1 Suspended95 enrolled